Wudy S A, Homoki J, Wachter U A, Teller W M
Abteilung Kinderheilkunde I, Universitätskinderklinik und Poliklinik Ulm.
Dtsch Med Wochenschr. 1997 Jan 3;122(1-2):3-10; discussion 11. doi: 10.1055/s-2008-1047569.
In 5-7% of all cases of congenital adrenogenital hyperplasia (AGH) there is 11 beta-hydroxylase deficiency (11 beta-HM). Its clinical picture is characterised by hyperandrogenism and, in some cases, arterial hypertension. The diagnosis of the enzyme deficiency depends on a reliable method of analysing the hormone in plasma and urine. As little is known and data often contradictory about the pattern of urinary steroid excretion in 11 beta-HM, these steroid metabolites were measured by a highly specific method.
The pattern of urinary excretion of steroids was determined by gas chromatography and mass spectrometry (GC/MS) in 16 children and adults (11 males, 5 females: mean age 9(8)/12 [2/12-20(3)/12] years) with 11 beta-HM.
In all patients there was greatly increased excretion of tetrahydrated (TH) and hexahydrated (HH) metabolites of 11-desoxycortisol (S) and desoxycorticosterone (DOC). The excretion of THS and THDOC was extremely increased in all patients. The metabolites 5 alpha-THS as well as 20 alpha- and 20 beta-isomers of HHS, not normal found in healthy persons, were present in 15 patients (94%), while the 20 alpha- and 20 beta-isomers of 5 alpha-HHS were demonstrated in 14 (88%). For the first time, 20 alpha- and 20 beta-isomers of 5 alpha-HHS were shown to be typical urinary steroid metabolites in 11-HM. The excretion of cortisol metabolites is typically decreased in 11 beta-HM. No corticosterone metabolites were found.
The urinary steroid excretion pattern, measured by GC/MS, is a noninvasive, highly specific and nonselective method in the differential diagnosis of abnormal steroid metabolism.
在所有先天性肾上腺皮质增生症(AGH)病例中,5%-7%存在11β-羟化酶缺乏(11β-HM)。其临床表现以雄激素过多为特征,部分病例伴有动脉高血压。酶缺乏的诊断依赖于可靠的血浆和尿液激素分析方法。由于对11β-HM患者尿类固醇排泄模式了解甚少且数据常常相互矛盾,因此采用高特异性方法对这些类固醇代谢产物进行了测定。
采用气相色谱和质谱联用(GC/MS)法测定了16例11β-HM儿童及成人(11例男性,5例女性;平均年龄9(8)/12 [2/12 - 20(3)/12]岁)的尿类固醇排泄模式。
所有患者11-脱氧皮质醇(S)和脱氧皮质酮(DOC)的四水合(TH)和六水合(HH)代谢产物排泄均显著增加。所有患者中THS和THDOC的排泄极度增加。健康人尿液中通常不存在的代谢产物5α-THS以及HHS的20α-和20β-异构体在15例患者(94%)中出现,而5α-HHS的20α-和20β-异构体在14例患者(88%)中被检测到。首次发现5α-HHS的20α-和20β-异构体是11-HM典型的尿类固醇代谢产物。11β-HM患者皮质醇代谢产物的排泄通常减少。未发现皮质酮代谢产物。
通过GC/MS测定的尿类固醇排泄模式是一种用于鉴别异常类固醇代谢的无创、高特异性且非选择性的方法。